IBDEI1EI ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22408,0)
 ;;=N12.^^102^1141^207
 ;;^UTILITY(U,$J,358.3,22408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22408,1,3,0)
 ;;=3^Pyelonephritis
 ;;^UTILITY(U,$J,358.3,22408,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,22408,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,22409,0)
 ;;=J30.9^^102^1141^210
 ;;^UTILITY(U,$J,358.3,22409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22409,1,3,0)
 ;;=3^Rhinitis, allergic
 ;;^UTILITY(U,$J,358.3,22409,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,22409,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,22410,0)
 ;;=B86.^^102^1141^212
 ;;^UTILITY(U,$J,358.3,22410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22410,1,3,0)
 ;;=3^Scabies
 ;;^UTILITY(U,$J,358.3,22410,1,4,0)
 ;;=4^B86.
 ;;^UTILITY(U,$J,358.3,22410,2)
 ;;=^108096
 ;;^UTILITY(U,$J,358.3,22411,0)
 ;;=M00.9^^102^1141^216
 ;;^UTILITY(U,$J,358.3,22411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22411,1,3,0)
 ;;=3^Septic Joint/Arthritis
 ;;^UTILITY(U,$J,358.3,22411,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,22411,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,22412,0)
 ;;=B02.9^^102^1141^220
 ;;^UTILITY(U,$J,358.3,22412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22412,1,3,0)
 ;;=3^Shingles/zoster
 ;;^UTILITY(U,$J,358.3,22412,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,22412,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,22413,0)
 ;;=J01.90^^102^1141^221
 ;;^UTILITY(U,$J,358.3,22413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22413,1,3,0)
 ;;=3^Sinusitis, acute
 ;;^UTILITY(U,$J,358.3,22413,1,4,0)
 ;;=4^J01.90
 ;;^UTILITY(U,$J,358.3,22413,2)
 ;;=^5008127
 ;;^UTILITY(U,$J,358.3,22414,0)
 ;;=J32.9^^102^1141^222
 ;;^UTILITY(U,$J,358.3,22414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22414,1,3,0)
 ;;=3^Sinusitis, chronic
 ;;^UTILITY(U,$J,358.3,22414,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,22414,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,22415,0)
 ;;=A49.01^^102^1141^160
 ;;^UTILITY(U,$J,358.3,22415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22415,1,3,0)
 ;;=3^Methicillin Susceptible Staphylococcus Aureus Infection
 ;;^UTILITY(U,$J,358.3,22415,1,4,0)
 ;;=4^A49.01
 ;;^UTILITY(U,$J,358.3,22415,2)
 ;;=^5000235
 ;;^UTILITY(U,$J,358.3,22416,0)
 ;;=R61.^^102^1141^233
 ;;^UTILITY(U,$J,358.3,22416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22416,1,3,0)
 ;;=3^Sweats/Night Sweats
 ;;^UTILITY(U,$J,358.3,22416,1,4,0)
 ;;=4^R61.
 ;;^UTILITY(U,$J,358.3,22416,2)
 ;;=^331970
 ;;^UTILITY(U,$J,358.3,22417,0)
 ;;=A51.0^^102^1141^234
 ;;^UTILITY(U,$J,358.3,22417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22417,1,3,0)
 ;;=3^Syphilis genital, primary
 ;;^UTILITY(U,$J,358.3,22417,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,22417,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,22418,0)
 ;;=A51.5^^102^1141^235
 ;;^UTILITY(U,$J,358.3,22418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22418,1,3,0)
 ;;=3^Syphilis,Early Latent
 ;;^UTILITY(U,$J,358.3,22418,1,4,0)
 ;;=4^A51.5
 ;;^UTILITY(U,$J,358.3,22418,2)
 ;;=^266730
 ;;^UTILITY(U,$J,358.3,22419,0)
 ;;=A52.8^^102^1141^236
 ;;^UTILITY(U,$J,358.3,22419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22419,1,3,0)
 ;;=3^Syphilis,Late Latent
 ;;^UTILITY(U,$J,358.3,22419,1,4,0)
 ;;=4^A52.8
 ;;^UTILITY(U,$J,358.3,22419,2)
 ;;=^266779
 ;;^UTILITY(U,$J,358.3,22420,0)
 ;;=A52.9^^102^1141^238
 ;;^UTILITY(U,$J,358.3,22420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22420,1,3,0)
 ;;=3^Syphilis,Tertiary
 ;;^UTILITY(U,$J,358.3,22420,1,4,0)
 ;;=4^A52.9
